COMMUNIQUÉS West-GlobeNewswire

Healthcare Integrated Technologies Inc. Welcomes Anand Ijju as its New Chief Technology Officer

10/04/2025 - 15:15

Knoxville, TN, April 10, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces the appointment of Anand Ijju [...]

BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States

10/04/2025 - 15:15

MELVILLE, N.Y., April 10, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage regenerative medicine innovator focused on stem cell- [...]

U.S. FDA clears first stapler designed for single-port robotic surgery

10/04/2025 - 15:15

Intuitive’s SureForm 45 stapler available for thoracic, colorectal, and urology procedures SUNNYVALE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive [...]

Selskabsmeddelelse 13 med vedhæftede fil

10/04/2025 - 15:13

Selskabsmeddelelse 13/2025 10. april 2025 BESTYRELSESMEDLEMMERS, DIREKTØRERS ELLER NÆRTSTÅENDE PERSONERS HANDEL MED STRATEGIC PARTNERS A/S AKTIER Se venligst vedlagte. Attachments Selskabsmeddelelse [...]

Lipozem Reviews (Customer Reports): I TRIED IT, Tracked It, and Exposed the Good, Bad & Shocking Truth!

10/04/2025 - 15:13

After 90+ Days of Personal Use, Lipozem’s Turmeric Hack Left Me Shocked—Here’s What Actually Happened (And Why Thousands Swear By It) LAKELAND, Fla., April 10, 2025 (GLOBE NEWSWIRE) -- Lipozem was not even on my radar [...]

Nature Communications Publishes Pivotal Data From Albatroz Therapeutics Demonstrating That Inhibiting Calnexin Alleviates Arthritis Symptoms and May Reverse Disease Progression

10/04/2025 - 15:12

Study uncovers insights about the progression of arthritis, the leading cause of disability which affects 1 in 5 adults and more than half of seniors age 75+ Publication demonstrates a novel therapeutic approach [...]

Eleos Expands Executive Leadership Bench Following Series C Fundraise

10/04/2025 - 15:00

Additional Hiring and Product Expansions Planned Through 2025 BOSTON and TEL AVIV, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Eleos, the leader in AI for behavioral health, today announced the appointment of a deep [...]

Elixir Medical Announces Launch of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Europe

10/04/2025 - 15:00

Novel IVL technology designed to deliver calcium fragmentation for treatment of moderate to severely calcified coronary artery lesions without requiring an energy source. IVL technology expands company’s innovative [...]

New York Plastic Surgical Group and Deep Blue Med Spa Receive State and National Recognition by Allergan Aesthetics

10/04/2025 - 15:00

Garden City, NY, April 10, 2025 (GLOBE NEWSWIRE) -- New York Plastic Surgical Group and Deep Blue Med Spa have been named the #1 provider of Allergan products in New York State. In addition, they have been ranked in the [...]

Over 53 Million Myeloma Milestones Shared During 2025 Myeloma Action Month

10/04/2025 - 14:45

Myeloma Action Month Global Campaign Celebrates Resilience, Strengthens Connections, and Inspires Hope in 52 Countries Worldwide STUDIO CITY, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- At the conclusion of this year’s [...]

Senti Bio Bolsters Scientific Advisory Board with Appointment of James B. Trager, Ph.D.

10/04/2025 - 14:45

Industry leader in the development and application of cellular therapies, including CAR NK products, for cancer Led development of multiple clinical candidates from conception through IND and early clinical development [...]

Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering

10/04/2025 - 14:35

SINGAPORE, April 10, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (“ CUPR ” or “the Company ”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the [...]

Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21

10/04/2025 - 14:31

WASHINGTON, April 10, 2025 (GLOBE NEWSWIRE) -- Geoff Dow, infectious disease product development expert and chief executive officer of 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company [...]

TYG Training Launches First Canadian Location in Whitby, Bringing Community-Driven Fitness to Durham Region

10/04/2025 - 14:30

WHITBY, Ontario, April 10, 2025 (GLOBE NEWSWIRE) -- TYG Training (TYG) has officially opened its first Canadian location in Whitby at 910 Dundas St W, Unit 104 — a boutique strength and conditioning club designed for [...]

Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency

10/04/2025 - 14:30

- Data from the largest retrospective analysis of ENPP1 Deficiency provides insights into the evolution of the disease’s serious cardiovascular and musculoskeletal complications - - Findings highlight the urgent need [...]

Pluri Announces Expansion of Intellectual Property Portfolio with Two Granted Patents for 3D Expansion of Immune Cells in the United States and Israel

10/04/2025 - 14:30

Latest granted patents reinforce Pluri’s position as a leader in Mucosal- A ssociated I nvariant T ( “ MAIT ” ) cell -based cell therap ies for solid cancers Pluri’s MAIT platform enable s commercial scale production of [...]

Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program

10/04/2025 - 14:30

NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 10, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT ) (" Conduit " or the “ Company ”) today announced that its Board of Directors has authorized a [...]

Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder

10/04/2025 - 14:25

Vancouver, Canada, April 10, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]

La Commission européenne approuve la quadrithérapie à base de DARZALEX® (daratumumab) par voie sous-cutanée de Johnson & Johnson chez les patients atteints d’un myélome multiple nouvellement diagnostiqué, quelle que soit leur éligibilité à la greffe

10/04/2025 - 14:11

Cet approbation renforce l’utilisation du daratumumab en traitement fondamental chez les patients atteints d’un myélome multiple nouvellement diagnostiqué, en faisant ainsi le seul anticorps anti-CD38 pour tous les [...]